Durwalumab w okołooperacyjnym leczeniu raka płuca od 1 lipca jest refundowany. Co o doborze chorych mówią analizy podgrup badania AEGEAN?
ASCO 2012: Ocenie poddano tivozanib, którego skuteczność porównano do sorafenibu w pierwszej (70%...
Kidney cancer, despite the constant upward trend in the incidence of this type of cancer (about...
Gastric cancer is one of the most frequent neoplasms. Although the incidence of gastric cancer...
Chemotherapy-induced peripheral neuropathy (CIPN) is a toxic neuropathy, a syndrome consisting of...
Endoglin (CD105) is an accessory receptor of transforming growth factor B. The highest synthesis,...
The prognosis of patients suffering from primary hepatocellular carcinoma (HCC) is unfavourable...
To present a case of a patient with cervical carcinoma in stage IIA who was diagnosed with pelvic...
Clinical examination is very important in the practice of medicine. In patients presenting with...
The technological progress that is currently being witnessed in the areas of diagnostic imaging,...
The cancer incidence in Wielkopolska in 2008 was one of the highest in the country and was higher...
To determine the relationship between the interval from surgery to initiation of radiation...
Although the survival for children with certain central nervous system (CNS) tumour types has...
Lekarze z Kliniki Onkologii i Chirurgii Onkologicznej Dzieci i Młodzieży w Instytucie Matki i...
W lipcu Narodowy Fundusz Zdrowia rozpoczął finansowanie badań w ramach profilaktyki...
Od 1 kwietnia 2025 r. durwalumab z tremelimumabem i czterema cyklami chemioterapii jest nową...
Z prognoz Międzynarodowej Agencji Badań nad Rakiem (IARC) wynika, że do 2050 r. zachorowalność...